Guidance documents represent the FDA’s current thinking on a particular subject. New guidance documents are listed here for three months.
Similar Posts
Handelnine Global Limited d/b/a as Navafresh Issues Nationwide Recall of Rheumacare Capsules by Virgo UAP Pharma Pvt. Ltd. (Virgo), Due to Elevated Lead Levels
Handelnine Global Limited d/b/a Navafresh is voluntarily recalling Lot Numbers CAM040 & CALO79-N of Rheumacare Capsules by Virgo UAP Pharma Pvt. Ltd. (Virgo) to the consumer level. In test conducted by the Food and Drug Administration the product has been found to contain lead at levels up to 11,100E6(R3) Good Clinical Practice (GCP)
The Food and Drug Administration is announcing the availability of a final guidance for industry entitled “E6(R3) Good Clinical Practice.” This revision incorporates flexible, risk-based approaches and embraces innovations in trial design, conduct, and technology.CDER Center for Clinical Trial Innovation (C3TI)
Enable and amplify existing and future CDER clinical trial innovation through enhanced communication and collaborationFDA In Brief: FDA issues 57 product-specific guidances, including 19 laying out path for developing generics to hard-to-copy “complex” medicines
FDA is posting 57 product-specific guidances to help industry generate evidence needed to support approval of generic drug applicationsBlendHouse Portland LLC. Portland, OR. EIR issued 04/26/2024
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 04/26/2024
Short Title (70 char) BlendHouse Portland LLC. Portland, OR. EIR issued 04/26/2024
FEI Number 3013670080
Firm Name BlendHouse Portland LLC
Record Type EIR
State OR
Establishment Type ManufacturerInotiv Inc. – 10/24/2025
Inotiv Inc. – 10/24/2025. Country: United States. Record Type: 483